Trial site
Froedtert Hospital & the Medical College of Wisconsin
- 28running trials
- 7closed trials
The trials here
What the 35 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma10 trials
- Acute myeloid leukaemia5 trials
- Chronic myeloid leukaemia4 trials
- Lung cancer3 trials
- Pancreatic cancer3 trials
- Prostate cancer3 trials
- Acute lymphoblastic leukaemia2 trials
- Bladder cancer2 trials
- Diffuse large B-cell lymphoma2 trials
- Kidney cancer2 trials
- Metastatic breast cancer2 trials
- Ovarian cancer2 trials
- and 16 more
- Phase
- Phase 215 trials
- Phase 114 trials
- Phase 1/22 trials
- Phase 2/31 trial
- Status
- Recruiting17 trials
- Active, not recruiting11 trials
- Completed3 trials
- Terminated3 trials
- Withdrawn1 trial
- Lead sponsor
- Medical College of Wisconsin16 trials
- Ichnos Sciences SA2 trials
- CellCentric Ltd.1 trial
- Columbia University1 trial
- Ehab L Atallah1 trial
- and 14 more
Running trials
Recruiting
Recruiting
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Recruiting
Recruiting
Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome
Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Recruiting
Recruiting
Recruiting
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Recruiting
Recruiting
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
Active, not recruiting
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Active, not recruiting
Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)
Active, not recruiting
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors
Recruiting
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma4 recruiting
- Pancreatic cancer3 recruiting
- Lung cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Bladder cancer1 recruiting
- Brain metastases1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Obesity1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Withdrawn
Completed
Terminated
Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma
Terminated
XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026